NAGIOS: RODERIC FUNCIONANDO

Prevention of medication related osteonecrosis of the jaw after dentoalveolar surgery : an institution's experience

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Prevention of medication related osteonecrosis of the jaw after dentoalveolar surgery : an institution's experience

Mostra el registre parcial de l'element

dc.contributor.author Sahin, Onur es
dc.contributor.author Tatar, Birkan es
dc.contributor.author Ekmekcioglu, Ceren es
dc.contributor.author Aliyev, Toghrul es
dc.contributor.author Odabasi, Onur es
dc.date.accessioned 2021-01-25T11:09:29Z
dc.date.available 2021-01-25T11:09:29Z
dc.date.issued 2020 es
dc.identifier.citation Sahin, Onur ; Tatar, Birkan ; Ekmekcioglu, Ceren ; Aliyev, Toghrul ; Odabasi, Onur. Prevention of medication related osteonecrosis of the jaw after dentoalveolar surgery : an institution's experience. En: Journal of Clinical and Experimental Dentistry, 12 8 2020: 771-776 es
dc.identifier.uri https://hdl.handle.net/10550/77511
dc.description.abstract Dentoalveolar surgery is a predisposing factor for medication related osteonecrosis of the jaw (MRONJ). The aim of our study was to evaluate the described surgical procedures to prevent the development of MRONJ after dentoalveolar surgery in patients receiving bisphosphonates. In this retrospective study, sixty-three dentoalveolar surgeries were performed on 44 patients taking bisphosphonate in accordance with the treatment procedures we described. The following procedures were applied to patients 1) use of antibiotics 2) performed dentoalveolar surgical procedures 3) fill the socket with leukocyte- and platelet-rich fibrin (L-PRF) 4) post-operative application of low level laser therapy through Nd: YAG laser 5) sutures were removed on post-op 14th day 6) long-term results were evaluated. Healing of all patients was uneventful. Complete mucosal healing was achieved in all patients at 1 month. There is no failure was observed in long-term follow-up. Because of the pathophysiology of MRONJ is not fully understood and has many risk factors, definitive protocols on prevention and treatment have not been established yet. Personal risk assessment is required for the prevention and treatment of MRONJ. The described surgical protocol may be considered to reduce the risk of developing MRONJ after dentoalveolar surgery due to its high success rate. es
dc.title Prevention of medication related osteonecrosis of the jaw after dentoalveolar surgery : an institution's experience es
dc.type journal article es_ES
dc.subject.unesco UNESCO::CIENCIAS MÉDICAS es
dc.identifier.doi 10.4317/jced.56837 es
dc.type.hasVersion VoR es_ES

Visualització       (963.8Kb)

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Cerca a RODERIC

Cerca avançada

Visualitza

Estadístiques